542
Views
0
CrossRef citations to date
0
Altmetric
Review

Nanoengineering Approaches to The Design of Artificial Antigen-Presenting Cells

&
Pages 1173-1189 | Published online: 25 Jun 2013
 

Abstract

Artificial antigen-presenting cells (aAPCs) have shown great initial promise for ex vivo activation of cytotoxic T cells. The development of aAPCs has focused mainly on the choice of proteins to use for surface presentation to T cells when conjugated to various spherical, microscale particles. We review here biomimetic nanoengineering approaches that have been applied to the development of aAPCs that move beyond initial concepts about aAPC development. This article also discusses key technologies that may be enabling for the development of nano- and micro-scale aAPCs with nanoscale features, and suggests several future directions for the field.

Financial & competing interests disclosure

The authors thank the NIH (R01-EB016721) for support and JC Sunshine thanks the Medical Scientist Training Program (MSTP) program for support. JJ Green is a consultant for NexImmune. Conflicts of interest are managed by the Johns Hopkins Medical Institutions Committee on Outside Interests. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

The authors thank the NIH (R01-EB016721) for support and JC Sunshine thanks the Medical Scientist Training Program (MSTP) program for support. JJ Green is a consultant for NexImmune. Conflicts of interest are managed by the Johns Hopkins Medical Institutions Committee on Outside Interests. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.